Compare Stocks → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CARANYSE:EIGTSE:MTY Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCARACara Therapeutics$0.91+4.6%$0.74$0.50▼$5.20$49.74M0.7736,299 shs637,269 shsEIGEmployers$45.40+0.9%$43.59$35.43▼$46.78$1.15B0.24140,471 shs155,636 shsMTYMTY Food GroupC$51.13-1.1%C$53.72C$47.76▼C$68.60C$1.24B1.9845,955 shs48,163 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCARACara Therapeutics+19.01%-3.74%+8.48%+13.27%-82.41%EIGEmployers+0.47%+1.40%-3.11%+13.66%+5.99%MTYMTY Food Group+0.15%-1.73%+4.63%-7.61%-14.78%Top Project Outperforms BTC in 2023… (Ad)According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCARACara Therapeutics4.5279 of 5 stars3.42.00.04.24.41.71.3EIGEmployers1.8431 of 5 stars2.33.02.50.01.11.71.3MTYMTY Food Group2.6472 of 5 stars3.20.01.70.00.60.82.5Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCARACara Therapeutics2.75Moderate Buy$9.75971.43% UpsideEIGEmployers2.50Moderate Buy$55.0021.15% UpsideMTYMTY Food Group2.43HoldC$59.8617.07% UpsideCurrent Analyst RatingsLatest EIG, MTY, MAB, DOM, and CARA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/28/2024CARACara TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.003/6/2024CARACara TherapeuticsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $10.003/5/2024CARACara TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.002/27/2024EIGEmployersJanney Montgomery ScottSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral2/20/2024EIGEmployersTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $55.002/20/2024MTYMTY Food GroupCIBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperformC$71.00 ➝ C$62.002/16/2024MTYMTY Food GroupScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector PerformC$62.00 ➝ C$55.002/16/2024MTYMTY Food GroupAcumen CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuyC$60.00 ➝ C$75.002/16/2024MTYMTY Food GroupRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket PerformC$65.00 ➝ C$60.002/16/2024MTYMTY Food GroupNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperformC$71.00 ➝ C$59.002/16/2024MTYMTY Food GroupTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHoldC$65.00 ➝ C$60.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCARACara Therapeutics$20.97M2.37N/AN/A$1.05 per share0.87EIGEmployers$850.90M1.35$4.96 per share9.16$39.42 per share1.15MTYMTY Food GroupC$1.17B1.06C$1.93 per share26.52C$33.35 per share1.53Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCARACara Therapeutics-$118.51M-$2.18N/AN/AN/A-565.21%-122.10%-89.64%5/20/2024 (Estimated)EIGEmployers$118.10M$4.4710.1612.27N/A13.88%10.54%2.82%4/25/2024 (Estimated)MTYMTY Food GroupC$104.08MC$4.2512.03∞0.758.90%13.60%4.52%4/10/2024 (Estimated)Latest EIG, MTY, MAB, DOM, and CARA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/4/202412/31/2023CARACara Therapeutics-$0.57-$0.59-$0.02-$0.59$2.34 million$3.00 million 2/16/2024Q4 2023EIGEmployers$1.00$1.40+$0.40$1.03$215.38 million$225.70 million 2/15/2024Q4 2023MTYMTY Food GroupC$0.99C$0.67-C$0.32C$0.67C$272.05 millionC$280.03 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCARACara TherapeuticsN/AN/AN/AN/AN/AEIGEmployers$1.122.47%+3.23%25.06%2 YearsMTYMTY Food GroupC$1.032.01%N/A24.24%N/ALatest EIG, MTY, MAB, DOM, and CARA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/14/2024EIGEmployersquarterly$0.282.5%2/27/20242/28/20243/13/20242/2/2024MTYMTY Food GroupQuarterlyC$0.281.97%2/2/20242/15/20242/15/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCARACara TherapeuticsN/A4.544.43EIGEmployersN/A0.450.45MTYMTY Food Group160.560.640.57OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCARACara Therapeutics44.66%EIGEmployers80.49%MTYMTY Food Group26.46%Insider OwnershipCompanyInsider OwnershipCARACara Therapeutics4.20%EIGEmployers1.40%MTYMTY Food Group16.12%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCARACara Therapeutics5554.66 million52.36 millionOptionableEIGEmployers71725.30 million24.95 millionOptionableMTYMTY Food Group7,32624.31 millionN/ANot OptionableEIG, MTY, MAB, DOM, and CARA HeadlinesSourceHeadlineFor Home and Humanity, Cota Explores Food Inequality Through Award-Winning Researchbcheights.com - March 15 at 10:46 AMMarietta Noon Lions delivers over six tons of food for Southeast Ohiomsn.com - March 12 at 2:39 AMMarinette restaurant becomes a food pantrymsn.com - March 11 at 3:07 PMWeld Food Bank’s Mobile Food Pantry brings aid to communities in needgreeleytribune.com - March 11 at 10:07 AMReturn Trends At MTY Food Group (TSE:MTY) Aren't Appealingfinance.yahoo.com - March 8 at 1:16 PMHappy Belly's HEAL Wellness QSR Announces the Signing of Its 19th Franchise, in the City of Hamilton, Ontariofinance.yahoo.com - March 5 at 10:37 AMMini food pantries popping up in North Jersey. Here's how you can helpnews.yahoo.com - February 24 at 5:12 PMConsumers are tired of price increases. Big brands are paying attention.msn.com - February 21 at 3:51 PMTSX flat; cooling domestic CPI cushions impact of Wall Street selloffmsn.com - February 20 at 6:44 PMWhy MTY Stock Tanked 14% After its Q4 Earnings Eventca.finance.yahoo.com - February 16 at 6:58 PMStocks in play: MTY Food Group Inc.ca.finance.yahoo.com - February 15 at 8:03 PMMTY Group reports fourth-quarter profit more than doubled compared with year earliertheglobeandmail.com - February 15 at 10:02 AMMTY Group reports Q4 profit more than doubled compared with year earliermsn.com - February 15 at 10:02 AMMTY FOOD GROUP INC WILL HOLD A CONFERENCE CALL TO DISCUSS ITS FOURTH QUARTER RESULTSfinance.yahoo.com - February 7 at 7:52 AMMarket movers: Why BB-T, CNR-T, MTY-T and more stocks are seeing action on Wednesdaytheglobeandmail.com - January 24 at 5:25 PMMTY Food Group Inc. raises dividend by 12% to CAD 0.28msn.com - January 24 at 5:25 PMMTY Food Group Hikes Quarterly Dividend by 12%marketwatch.com - January 24 at 7:51 AMMTY INCREASES ITS QUARTERLY DIVIDEND BY 12%finance.yahoo.com - January 24 at 7:51 AMMTY Food Group Inc.wsj.com - January 23 at 11:50 AMMTY Food Group Inc (MTY)investing.com - January 23 at 11:50 AMWhy the largest group of dietitians and nutritionists doesn't recommend food detoxksl.com - January 21 at 4:28 AMLongmont Set to Get Its First Food Hall in Maywestword.com - January 19 at 1:03 PMCommunity Food Bank of New Jersey surpasses 1 billion meal milestonecbsnews.com - January 11 at 7:18 PMMTY Food Group Inc MTYFFmorningstar.com - January 6 at 9:04 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines5 Stocks with Unusually Large Short InterestMarch 8, 2024 7:30 AMView 5 Stocks with Unusually Large Short InterestPure Storage and Nvidia Proves AI-Ready Infrastructure Reigns March 4, 2024 9:20 AMView Pure Storage and Nvidia Proves AI-Ready Infrastructure Reigns MarketBeat Week in Review – 3/4 – 3/8March 9, 2024 7:00 AMView MarketBeat Week in Review – 3/4 – 3/8Plug Power Pivots, But a Stock Price Reversal Is UnlikelyMarch 4, 2024 9:10 AMView Plug Power Pivots, But a Stock Price Reversal Is UnlikelyThis Freight Stock Just Got an Upgrade and Institutional BuyersMarch 13, 2024 9:51 AMView This Freight Stock Just Got an Upgrade and Institutional BuyersAll Headlines Company DescriptionsCara TherapeuticsNASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.EmployersNYSE:EIGEmployers Holdings, Inc., through its subsidiaries, operates in the commercial property and casualty insurance industry primarily in the United States. The company operates in two segments, Employers and Cerity. It offers workers' compensation insurance to small businesses in low to medium hazard industries under the Employers and Cerity brands. The company markets its products through local, regional, and national agents and brokers; alternative distribution channels; and national, regional, and local trade groups and associations, as well as directly to customers. Employers Holdings, Inc. was founded in 2000 and is based in Henderson, Nevada.MTY Food GroupTSE:MTYMTY Food Group Inc. operates and franchises quick-service, fast-casual, and casual dining restaurants in Canada, the United States, and internationally. It also sells retail products under a multitude of banners. The company was formerly known as iNsu Innovations Group Inc. and changed its name to MTY Food Group Inc. in July 2003. MTY Food Group Inc. was founded in 1979 and is headquartered in Saint-Laurent, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.